Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


31.07.2017

2 Am J Respir Crit Care Med
3 Antimicrob Agents Chemother
5 Eur Respir J
1 Infect Immun
1 J Clin Microbiol
3 J Immunol
1 J Infect
4 PLoS One
1 Trop Med Int Health


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Respir Crit Care Med

  1. CLAYTON K, Polak ME, Woelk CH, Elkington P, et al
    Gene Expression Signatures in Tuberculosis Have Greater Overlap with Autoimmune Than Infectious Diseases.
    Am J Respir Crit Care Med. 2017 Jul 28. doi: 10.1164/rccm.201706-1248.
    PubMed     Text format    

  2. NEMES E, Rozot V, Geldenhuys H, Bilek N, et al
    Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of M. tuberculosis Infection.
    Am J Respir Crit Care Med. 2017 Jul 24. doi: 10.1164/rccm.201704-0817.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  3. ALSULTAN A, Furin JJ, Du Bois J, van Brakel E, et al
    Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01066.
    PubMed     Text format     Abstract available

  4. MOURIK BC, de Knegt GJ, Verbon A, Mouton JW, et al
    Assessment of bactericidal drug activity and treatment outcome in a mouse tuberculosis model using a clinical Beijing strain.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00696.
    PubMed     Text format     Abstract available

  5. PANG Y, Zong Z, Huo F, Jing W, et al
    In vitro drug susceptibility of bedaquiline, delamanid, linezolid, clofazimine, moxifloxacin, and gatifloxacin against extensively drug -resistant tuberculosis from Beijing, China.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.00900.
    PubMed     Text format     Abstract available


    Eur Respir J

  6. ONI T, Berkowitz N, Kubjane M, Goliath R, et al
    Trilateral overlap of tuberculosis, diabetes and HIV-1 in a high-burden African setting: implications for TB control.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  7. GUGLIELMETTI L, Varaine F, Huerga H, Bonnet M, et al
    Shortened multidrug-resistant tuberculosis treatment in settings with a high prevalence of ofloxacin resistance.
    Eur Respir J. 2017;50.
    PubMed     Text format    

  8. ZENNER D, Loutet MG, Harris R, Wilson S, et al
    Evaluating 17 years of latent tuberculosis infection screening in north-west England: a retrospective cohort study of reactivation.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  9. AHMAD KHAN F, Salim MAH, du Cros P, Casas EC, et al
    Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses.
    Eur Respir J. 2017;50.
    PubMed     Text format     Abstract available

  10. MULLERPATTAN JB, Nikam C, Sharma U, Rodrigues C, et al
    Rifampicin-resistant tuberculosis: what is the best initial empiric regimen in Mumbai, India?
    Eur Respir J. 2017;50.
    PubMed     Text format    


    Infect Immun

  11. NAIK SK, Padhi A, Ganguli G, Sengupta S, et al
    Mice bone marrow Sca-1+/CD44+mesenchymal stem cells kill avirulent mycobacteria but not Mycobacterium tuberculosis through modulation of cathelicidin expression via p38 MAPK dependent pathway.
    Infect Immun. 2017 Jul 24. pii: IAI.00471-17. doi: 10.1128/IAI.00471.
    PubMed     Text format     Abstract available


    J Clin Microbiol

  12. ALEXANDER DC, Vasireddy R, Vasireddy S, Philley JV, et al
    Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease.
    J Clin Microbiol. 2017;55:574-584.
    PubMed     Text format     Abstract available


    J Immunol

  13. NAGALINGAM G, Vinuesa CG, Britton WJ, Saunders BM, et al
    Modulation of Roquin Function in Myeloid Cells Reduces Mycobacterium tuberculosis-Induced Inflammation.
    J Immunol. 2017 Jul 26. pii: ji1602069. doi: 10.4049/jimmunol.1602069.
    PubMed     Text format     Abstract available

  14. ORME IM
    Pillars Article: The Kinetics of Emergence and Loss of Mediator T Lymphocytes Acquired in Response to Infection with Mycobacterium Tuberculosis. J. Immunol. 1987. 138: 293-298.
    J Immunol. 2017;199:833-838.
    PubMed     Text format    

  15. COOPER AM
    Defining the Kinetics, Phenotype, and Function of T Cells Induced by Mycobacterium tuberculosis: Pillar of Immunity to Tuberculosis.
    J Immunol. 2017;199:831-832.
    PubMed     Text format    


    J Infect

  16. VILLAR-HERNANDEZ R, Latorre I, Minguez S, Diaz J, et al
    Use of IFN-gamma and IP-10 detection in the diagnosis of latent tuberculosis infection in patients with inflammatory rheumatic diseases.
    J Infect. 2017 Jul 24. pii: S0163-4453(17)30248.
    PubMed     Text format     Abstract available


    PLoS One

  17. EVANS D, Schnippel K, Govathson C, Sineke T, et al
    Treatment initiation among persons diagnosed with drug resistant tuberculosis in Johannesburg, South Africa.
    PLoS One. 2017;12:e0181238.
    PubMed     Text format     Abstract available

  18. JEON AB, Obregon-Henao A, Ackart DF, Podell BK, et al
    2-aminoimidazoles potentiate ss-lactam antimicrobial activity against Mycobacterium tuberculosis by reducing ss-lactamase secretion and increasing cell envelope permeability.
    PLoS One. 2017;12:e0180925.
    PubMed     Text format     Abstract available

  19. KO Y, Song J, Lee SY, Moon JW, et al
    Does repeated pleural culture increase the diagnostic yield of Mycobacterium tuberculosis from tuberculous pleural effusion in HIV-negative individuals?
    PLoS One. 2017;12:e0181798.
    PubMed     Text format     Abstract available

  20. MYLLYMAKI H, Niskanen M, Oksanen KE, Sherwood E, et al
    Identification of novel antigen candidates for a tuberculosis vaccine in the adult zebrafish (Danio rerio).
    PLoS One. 2017;12:e0181942.
    PubMed     Text format     Abstract available


    Trop Med Int Health

  21. LIU Z, Pan A, Wu B, Zhou L, et al
    Feasibility of a new model for early detection of multidrug resistant tuberculosis patients in a developed setting of eastern China.
    Trop Med Int Health. 2017 Jul 26. doi: 10.1111/tmi.12934.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: